ZARRILLI STEPHEN T
SEC Form 4 insider trading activity
ZARRILLI STEPHEN T has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
On the most recent filing, ZARRILLI STEPHEN T is listed as Director at GLOBUS MEDICAL INC. Inside the rolling window, ZARRILLI STEPHEN T reported no open-market purchases and 2 open-market sales totaling $4.3M in GMED. The largest disclosed transaction in the window is a sale of 25,000 GMED shares on Aug 18, 2026, worth $2.2M.
Companies traded
Other insiders at GMED
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ZARRILLI STEPHEN T made?
ZARRILLI STEPHEN T has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does ZARRILLI STEPHEN T trade?
ZARRILLI STEPHEN T has filed SEC Form 4 disclosures for 1 company, including GMED.
When was ZARRILLI STEPHEN T's most recent SEC Form 4 filing?
ZARRILLI STEPHEN T's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.
What is ZARRILLI STEPHEN T's total buy and sell value in the current window?
Inside the rolling retention window, ZARRILLI STEPHEN T bought $0 and sold $4.3M based on SEC Form 4 filings.
What was ZARRILLI STEPHEN T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 GMED shares on 2026-08-18, worth $2.2M, per SEC Form 4 filings.